See the DrugPatentWatch profile for ozempic

Ozempic, a type 2 diabetes medication, has been reported to impact meal sizes, as suggested by recent news articles [3][2]. The drug, which contains the active ingredient semaglutide, has been observed to reduce appetite and lead to weight loss [1].

According to a CNN article, the use of Ozempic has led to a decrease in meal sizes and a shift in consumer behavior [3]. The New York Post also reports that the popularity of Ozempic has caused restaurants to adapt their menus and offerings, as patients using the medication are consuming less food [2].

The drug's ability to reduce appetite is a result of its mechanism of action. Ozempic works by mimicking a hormone in the body that helps control blood sugar, insulin levels, digestion, and feelings of fullness [1].

In summary, Ozempic has been observed to impact meal sizes by reducing appetite and leading to weight loss. This has resulted in changes in consumer behavior and adaptations in the restaurant industry.

Sources:

1. <https://www.drugpatentwatch.com/p/tradename/OZEMPIC>
2. <https://nypost.com/2023/03/14/ozempic-craze-has-restaurants-scrambling-to-adapt/>
3. <https://www.cnn.com/2023/10/05/investing/ozempic-food-companies/index.html>